Premium
Comparison of 2,17‐dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression—an index of tumor therapy evaluation
Author(s) -
Tallky R. W.,
Brennan M. J.,
Vaitkevicius V. K.,
Beckett V. L.
Publication year - 1963
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(196304)16:4<440::aid-cncr2820160404>3.0.co;2-g
Subject(s) - medicine , breast cancer , general hospital , metastatic breast cancer , oncology , clinical oncology , cancer , family medicine